Source: Medical Device Network

Nanomix: Nanomix and Mobility Health to develop test for Covid-19 antibodies

The companies will seek CLIA Lab Emergency Use Authorization for the test from the US FDA. The post Nanomix and Mobility Health to develop test for Covid-19 antibodies appeared first on Medical Device Network.

Read full article »

Nanomix's Competitors | Nanomix's News | Nanomix's Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

25-100

CEO

Thomas Schlumpberger

CEO Approval Rating

82/100

Nanomix is a California-based medical device company that manufactures and supplies point of care immunoassay and chemical diagnostic systems for the healthcare industry.